Phenylacetic acid derivatives as hPPAR agonists
- 7 March 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (7) , 1277-1280
- https://doi.org/10.1016/s0960-894x(03)00115-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Amphipathic 3-Phenyl-7-propylbenzisoxazoles; human pPaR γ, δ and α agonistsBioorganic & Medicinal Chemistry Letters, 2003
- Potentiation of Insulin Signaling in Tissues of Zucker Obese Rats After Acute and Long-Term Treatment With PPARγ AgonistsDiabetes, 2002
- Novel Peroxisome Proliferator-activated Receptor (PPAR) γ and PPARδ Ligands Produce Distinct Biological EffectsJournal of Biological Chemistry, 1999
- The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiationBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Down-regulation of the Expression of the Obese Gene by an Antidiabetic Thiazolidinedione in Zucker Diabetic Fatty Rats and db/db MiceJournal of Biological Chemistry, 1996
- The Glitazone Family of Antidiabetic AgentsCurrent Pharmaceutical Design, 1996
- The Structure−Activity Relationship between Peroxisome Proliferator-Activated Receptor γ Agonism and the Antihyperglycemic Activity of ThiazolidinedionesJournal of Medicinal Chemistry, 1996
- Studies on antidiabetic agents. I. Synthesis of 5-(4-(2-methyl-2-phenylpropoxy)-benzyl)thiazolidine-2,4-dione (AL-321) and related compounds.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982